News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.



8/29/2007 7:59:09 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--ParagonDx LLC, a leader in genetic and molecular testing diagnostics, has acquired the assets of Gentris Diagnostics, Inc, a subsidiary of Gentris Corporation. As a stand-alone company, ParagonDx will focus on developing molecular diagnostic products for laboratories. These products are intended to enhance medical care by providing early diagnostic information rapidly. This should benefit patients and save money for the healthcare system. Michael P. Murphy, former President and CEO of Gentris Corporation, will serve as the President and CEO of ParagonDx.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES